Drug Shortage Report for TEVA-AMPHETAMINE XR
Report ID | 195594 |
Drug Identification Number | 02439263 |
Brand name | TEVA-AMPHETAMINE XR |
Common or Proper name | TEVA-AMPHETAMINE XR |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MIXED SALTS AMPHETAMINE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | 2023-06-30 |
Actual end date | 2023-07-04 |
Shortage status | Resolved |
Updated date | 2023-07-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-07-05 | English | Compare |
v5 | 2023-07-04 | French | Compare |
v4 | 2023-07-04 | English | Compare |
v3 | 2023-06-20 | English | Compare |
v2 | 2023-06-19 | French | Compare |
v1 | 2023-06-19 | English | Compare |
Showing 1 to 6 of 6